Clinical Trials Quantum Applications Antibiotics Bioactive Compounds Therapeutics Therapeutics Development AI in Healthcare Natural Products Antibiotic Development Quantum Computing Applications Antibody-Drug Conjugates AI in Drug Development Research and Development Molecular Screening Compounds Targeted Therapies Combination Therapy Biotechnology Membrane Proteins Clinical Research Antimicrobial Agents AI Integration Personalized Medicine Clinical Development Repurposing Drugs Computational Drug Discovery Targeted Therapy Clinical Applications Chemical Reactions Treatment Development Immunology Molecular Design Research Studies AI in Drug Discovery Artificial Intelligence Patient Treatment CNS Disorders Antibiotic Resistance AI Technology Innovative Technologies Molecular Interactions Antimalarial Drugs
Backed by a $650 million up-front payment, the agreement places Pfizer in charge of global development for a 12-program cancer portfolio discovered and advanced by Innovent.
